During the session, different approaches (surgery via laparotomy, surgery via laparoscopy, or no surgery) to patients with complete response after the treatment of neoadjuvant chemotherapy in advanced epithelial ovarian carcinoma will be discussed. The results of randomized trials will be presented in order to determine the most appropriate approach/approaches for this group of patients.

This session will provide three oral abstract presentations focused on diversity equity inclusion. Focused plenary presenters were also requested to submit E-Posters which you can find in the E-Poster Gallery on the Virtual Platform and IGCS 2022 Mobile App.

This session will focus on recent paradigm changes in treatment landscape of endometrial cancer with a focus on treatment of low grade endometrial cancer. Different approaches to treatment including chemotherapy, checkpoint inhibitor therapy, and combination therapy with pembrolizumab and lenvatanib will be discussed. The role of hormonal therapies (i.e.megesterol acetate, letrozole, etc) and hormonal combination therapies in the treatment of low grade endometrial cancer will be highlighted.